Microsoft vs Revvity Inc — how do they compare? Microsoft trades at $396.43 (market cap $2.99T), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: Microsoft is far larger — about 251.9× Revvity Inc's market cap, and Microsoft pays the higher dividend (0.9%). Which is the better fit depends on your goals.
| MSFT | RVTY | |
|---|---|---|
Market Cap | $2.99T | $11.87B |
Volume | 36,654,621 | — |
Sector | Technology | Technology |
52-Week High | $542.07 | $117.75 |
52-Week Low | $352.83 | $82.26 |
Enterprise Value | $2.97T | $14.36B |
Dividend Yield | 0.9% | 0.26% |
Signals from Pluang's Aura AI — not financial advice
Microsoft (MSFT) trades at $397.75, up 1.0% today, with a bullish technical signal from moving averages and strong fundamental performance. Revenue grew to $281.72B in 2025, with net income of $101.83B, and the company has beaten EPS estimates for three consecutive quarters. Analysts maintain an 80.49% buy rating with a consensus price target of $546.70, highlighting AI leadership through Azure and Copilot.
The outlook remains positive given robust earnings growth and AI-driven opportunities, but risks include elevated capital expenditure concerns and competitive pressures. Valuation metrics like a P/E of 23.96 and P/S of 9.43 suggest the stock is fairly priced, supporting a long-term bullish view tempered by near-term volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →